Viability of a new home program of forced spirometry with bronchodilator response measurement in the assessment of patients with asthma

dc.contributor.authorCabrerizo-Carreño, Héctor
dc.contributor.authorBellver Asperilla, Cristina
dc.contributor.authorRomero-Ortiz, Ana Maria
dc.contributor.authorSantos Pérez, Salud
dc.contributor.authorAso, Samantha
dc.contributor.authorBordas Martínez, Jaume
dc.contributor.authorFabrellas i Padrès, Núria
dc.contributor.authorGuix Comellas, Eva Maria
dc.contributor.authorSuárez Cuartín, Guillermo Rafael
dc.contributor.authorMuñoz Esquerre, Mariana
dc.date.accessioned2025-07-21T12:12:28Z
dc.date.available2025-07-21T12:12:28Z
dc.date.issued2025-06-01
dc.date.updated2025-07-21T12:12:28Z
dc.description.abstractBackground: Home spirometry using portable devices offers a potential alternative for asthma management by reducing hospital dependence and improving accessibility. This study aimed to assess the feasibility of a home spirometry program with bronchodilator response (BDR) testing performed without direct medical supervision. Methods: A prospective observational study was conducted with 47 asthma patients from a tertiary hospital. Participants received clear instructions and performed forced spirometry with BDR testing at home using a portable device. The primary outcomes included spirometry quality, variability compared to hospital tests, and patient satisfaction. Results: A total of 78% of participants achieved high-quality spirometry (A or B, according to ATS/ERS -criteria), despite greater variability in forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) compared to hospital tests. However, the results remained clinically acceptable. Patients reported high satisfaction with the device, highlighting its ease of use and convenience. Conclusions: Home spirometry with BDR testing is a feasible tool for asthma follow-up, maintaining acceptable quality while reducing hospital-based testing. Although improvements are needed to minimize variability and enhance consistency, this program has the potential to optimize asthma management, increase accessibility, and reduce the burden on healthcare facilities.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec758822
dc.identifier.issn1828-695X
dc.identifier.pmid40464088
dc.identifier.urihttps://hdl.handle.net/2445/222414
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.5826/mrm.2025.1024
dc.relation.ispartofMultidisciplinary Respiratory Medicine, 2025, vol. 20
dc.relation.urihttps://doi.org/10.5826/mrm.2025.1024
dc.rightscc-by-nc (c) Cabrerizo Carreño, H. et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationEspirometria
dc.subject.classificationAsma
dc.subject.classificationSatisfacció dels pacients
dc.subject.otherSpirometry
dc.subject.otherAsthma
dc.subject.otherPatient satisfaction
dc.titleViability of a new home program of forced spirometry with bronchodilator response measurement in the assessment of patients with asthma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
894684.pdf
Mida:
817.08 KB
Format:
Adobe Portable Document Format